Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the Inhaled Insulin Treatment Questionnaire (IITQ)

被引:0
|
作者
Richard R Rubin
Mark Peyrot
机构
[1] The Johns Hopkins University School of Medicine,Department of Medicine
[2] The Johns Hopkins University School of Medicine,Department of Pediatrics
[3] Loyola University Maryland,Department of Sociology
关键词
Insulin Therapy; Patient Report Outcome; Treatment Satisfaction; Insulin Aspart; Pramlintide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Inhaled insulin treatment compliance by 46 patients using AERx® iDMS Insulin Diabetes Management System.
    Clauson, P
    Okikawa, J
    Cramer, J
    DIABETOLOGIA, 2003, 46 : A46 - A46
  • [22] Compliance with inhaled insulin treatment using AERx® iDMS insulin diabetes management system
    Cramer, J
    Okikawa, J
    Clauson, P
    DIABETES, 2003, 52 : A103 - A103
  • [23] Effect of Technosphere Inhaled Insulin on Quality of Life and Treatment Satisfaction
    Peyrot, Mark
    Rubin, Richard R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (01) : 49 - 55
  • [24] Bioavailibility and pharmacokinetic properties of inhaled dry powder Technosphere/Insulin
    Steiner, S
    Rave, K
    Heise, T
    Harzar, O
    Flacke, F
    Pfützner, A
    Heinemann, L
    DIABETES, 2000, 49 : A126 - A126
  • [25] Inhaled insulin -: a new therapeutic option in the treatment of diabetes mellitus
    Díez, JJ
    Iglesias, P
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (02) : 191 - 200
  • [26] AIR® inhaled insulin system:: a novel insulin-delivery system for patients with diabetes
    Rosenstock, Julio
    Muchmore, Douglas
    Swanson, Diana
    Schmitke, Jennifer
    EXPERT REVIEW OF MEDICAL DEVICES, 2007, 4 (05) : 683 - 692
  • [27] Treatment satisfaction with inhaled insulin in patients with type 1 diabetes - A randomized controlled trial
    Gerber, RA
    Cappelleri, JC
    Kourides, IA
    Gelfand, RA
    DIABETES CARE, 2001, 24 (09) : 1556 - 1559
  • [28] Reproducibility of inhaled and subcutaneous insulin in Type 2 diabetic patients
    Perera, AD
    Kapitza, C
    Nosek, L
    Heinemann, LW
    Shapiro, DA
    Fishman, RS
    Heise, TC
    DIABETOLOGIA, 2001, 44 : A212 - A212
  • [29] Identifying factors that affect patients' willingness to pay for inhaled insulin
    Pinto, Sharrel L.
    Holiday-Goodman, Monica
    Black, Curtis D.
    Lesch, David
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2009, 5 (03): : 253 - 261
  • [30] Inhaled insulin: clinical results in type 2 diabetic patients
    Selam, JL
    DIABETES & METABOLISM, 2001, 27 (05): : S28 - S32